Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 28,370 | 25,731 | 28,800 | 25,763 | 30,364 |
| Cost of Goods | 15,446 | 14,005 | 16,205 | 14,285 | 16,501 |
| Gross Profit | 12,924 | 11,726 | 12,595 | 11,478 | 13,863 |
| Operating Expenses | 13,257 | 12,506 | 12,701 | 12,913 | 12,243 |
| Operating Income | 113 | -775 | 99 | -1,150 | 2,121 |
| Interest Expense | 205 | 204 | 215 | 222 | 238 |
| Other Income | -229 | -117 | -311 | -392 | -711 |
| Pre-tax Income | -321 | -1,096 | -427 | -1,764 | 1,172 |
| Income Tax | 16,819 | -249 | -776 | -363 | 1,191 |
| Net Income Continuous | -17,140 | -847 | 349 | -1,401 | -19 |
| Net Income | $-17,140 | $-847 | $349 | $-1,401 | $-19 |
| EPS Basic Total Ops | -5.20 | -0.20 | 0.10 | -0.40 | 0.00 |
| EPS Basic Continuous Ops | -5.10 | -0.25 | 0.10 | -0.43 | 0.02 |
| EPS Diluted Total Ops | -5.20 | -0.20 | 0.10 | -0.40 | 0.00 |
| EPS Diluted Continuous Ops | -5.09 | -0.25 | 0.10 | -0.43 | 0.01 |
| EBITDA(a) | $1,412 | $307 | $1,199 | $28 | $3,225 |